Dr. Zanos was invited as an expert contributor to the “TO AITION” project’s Q&A section. “TO AITION” is a groundbreaking EU-funded project investigating the complex relationship between cardiovascular disease (CVD) and depression, aiming to uncover underlying mechanisms and develop novel tools for prevention, diagnosis, and treatment. In this role, Dr. Zanos addressed critical questions about depression, leveraging his expertise in neuropharmacology. The questions covered a range of important topics, including the genetic factors in depression, the role of neurotransmitters like serotonin and dopamine, the challenges of treatment-resistant depression, and the potential of personalized medicine in improving treatment outcomes. Dr. Zanos’s selection as an expert for this initiative highlights the Zanos Lab’s significant contributions to the field and underscores their commitment to advancing understanding of depression within the context of its comorbidity with cardiovascular disease.

For more info read: https://www.to-aition.eu/qadepression